| Net income | 37.8M |
| Depreciation and amortization | 24.8M |
| Stock-based compensation | 4.8M |
| Loss (gain) on disposal of assets | |
| Deferred income taxes | -6.2M |
| Impairment charges | |
| Provision for losses on receivables, net | |
| Accounts receivable | |
| Prepaid expenses and other current assets | |
| Other assets | |
| Accounts payable | |
| Deferred revenue | |
| Other current liabilities | |
| Long-term income taxes payable, net of long-term income taxes receivable | |
| Other liabilities | |
| Net cash (used in) provided by operating activities | 65.4M |
| Purchases of marketable securities | |
| Proceeds from sale of marketable securities | |
| Purchases of property and equipment | -18.8M |
| Acquisition of businesses | |
| Proceeds from sale of assets | |
| Net cash used in investing activities | -18.5M |
| Proceeds from issuance of common stock | 7.4M |
| Borrowings under lines of credit | 80M |
| Repayments under lines of credit | -61.1M |
| (Repayments) borrowings under long-term debt | |
| Purchase of non-controlling interests | |
| Net cash provided by (used in) financing activities | 26.3M |
| Effect of exchange rate changes on cash and cash equivalents | 4M |
| Net (decrease) increase in cash and cash equivalents | 77.2M |
| Cash and cash equivalents at beginning of year | 248.6M |
| Cash and cash equivalents at end of year | 325.8M |
| Interest paid | 4.4M |
| Income taxes, net of refunds | 2M |